ClinicalTrials.govpublic full text
A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
cholangiocarcinoma non-resectable, cholangiocarcinoma metastatic, idh-1 mutation, cholangiocarcinoma non-resectable with an idh-1 mutation, cholangiocarcinoma metastatic with an idh-1 mutation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 812394
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.